The usefulness of KL-6 and SP-D for the diagnosis and management of chronic hypersensitivity pneumonitis

Respiratory Medicine

Volumn 109, Issue 12, 2015, Pages 1576-1581

  Okamoto, Tsukasa ^a   Fujii, Mayumi ^b   Furusawa, Haruhiko ^a   Tsuchiya, Kimitake ^a   Miyazaki, Yasunari ^a   Inase, Naohiko ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Soka Municipal Hospital   (Japan)

Author keywords

Acute exacerbation; Hypersensitivity pneumonitis; Idiopathic pulmonary fibrosis; Krebs von den Lungen 6; Surfactant protein D

Indexed keywords

BIOLOGICAL MARKER; KREB VON DEN LUNGEN 6 PROTEIN; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; MUC1 PROTEIN, HUMAN; MUCIN 1; PREDNISOLONE;

ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; CHRONIC DISEASE; CLINICAL EVALUATION; CLINICAL STUDY; COLLAGEN VASCULAR DISEASE ASSOCIATED INTERSTITIAL PNEUMONIA; DISEASE EXACERBATION; FEMALE; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LUNG LAVAGE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOIDOSIS; VASCULAR DISEASE; ALVEOLITIS, EXTRINSIC ALLERGIC; DIFFERENTIAL DIAGNOSIS; EVALUATION STUDY; IDIOPATHIC PULMONARY FIBROSIS; LUNG SARCOIDOSIS; METABOLISM; TREATMENT OUTCOME;

ADULT; AGED; ALVEOLITIS, EXTRINSIC ALLERGIC; ANTI-INFLAMMATORY AGENTS; BIOMARKERS; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; MUCIN-1; PREDNISOLONE; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY; TREATMENT OUTCOME;

EID: 84949806617     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2015.10.005     Document Type: Article

References (39)

1. Y. Lacasse, M. Selman, U. Costabel, and et al. Classification of hypersensitivity pneumonitis: a hypothesis Int. Arch. Allergy Immunol. 149 2009 161 166
2. Y. Ohtani, N. Inase, S. Miyake, and et al. Fatal outcome in chronic bird fancier's lung Am. J. Med. 112 2002 588 590
3. T. Oyama, N. Kohno, A. Yokoyama, and et al. Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin Lung 175 1997 379 385
4. S. Fukaya, H. Oshima, K. Kato, and et al. KL-6 as a novel marker for activities of interstitial pneumonia in connective tissue diseases Rheumatol. Int. 19 2000 223 225
5. H. Ohnishi, A. Yokoyama, Y. Yasuhara, and et al. Circulating KL-6 levels in patients with drug induced pneumonitis Thorax 58 2003 872 875
6. A. Yokoyama, K. Kondo, M. Nakajima, and et al. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis Respirology 11 2006 164 168
7. H. Takahashi, M. Shiratori, A. Kanai, and et al. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D Respirology 11 Suppl. 2006 S51 S54
8. H. Satoh, K. Kurishima, H. Ishikawa, and et al. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases J. Intern Med. 260 2006 429 434
9. H. Ohnishi, A. Yokoyama, K. Kondo, and et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases Am. J. Respir. Crit. Care Med. 165 2002 378 381
10. N. Kohno, S. Kyoizumi, Y. Awaya, and et al. New serum indicator of interstitial pneumonitis activity. Sialylated carbohydrate antigen KL-6 Chest 96 1989 68 73
11. T. Takahashi, M. Munakata, Y. Ohtsuka, and et al. Serum KL-6 concentrations in dairy farmers Chest 118 2000 445 450
12. N. Inase, Y. Ohtani, Y. Usui, and et al. Chronic summer-type hypersensitivity pneumonitis: clinical similarities to idiopathic pulmonary fibrosis Sarcoidosis Vasc. Diffuse Lung Dis. 24 2007 141 147
13. R. Janssen, J.C. Grutters, H. Sato, and et al. Analysis of KL-6 and SP-D as disease markers in bird fancier's lung Sarcoidosis Vasc. Diffuse Lung Dis. 22 2005 51 57
14. T. Okamoto, Y. Miyazaki, T. Ogura, and et al. A nationwide epidemiological survey of chronic hypersensitivity pneumonitis in Japan Respir. Investig. 51 2013 191 199
15. Y. Ohtani, S. Saiki, Y. Sumi, and et al. Clinical features of recurrent and insidious chronic bird fancier's lung Ann. Allergy Asthma Immunol. 90 2003 604 610
16. Y. Yoshizawa, Y. Ohtani, H. Hayakawa, and et al. Chronic hypersensitivity pneumonitis in Japan: a nationwide epidemiologic survey J. Allergy Clin. Immunol. 103 1999 315 320
17. G. Raghu, H.R. Collard, J.J. Egan, and et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management Am. J. Respir. Crit. Care Med. 183 2011 788 824
18. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001 Am. J. Respir. Crit. Care Med. 165 2002 277 304
19. G.W. Hunninghake, U. Costabel, M. Ando, and et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders Sarcoidosis Vasc. Diffuse Lung Dis. 16 1999 149 173
20. H.R. Collard, B.B. Moore, K.R. Flaherty, and et al. Acute exacerbations of idiopathic pulmonary fibrosis Am. J. Respir. Crit. Care Med. 176 2007 636 643
21. Y. Ohtani, S. Saiki, M. Kitaichi, and et al. Chronic bird fancier's lung: histopathological and clinical correlation. An application of the 2002 ATS/ERS consensus classification of the idiopathic interstitial pneumonias Thorax 60 2005 665 671
22. W.D. Travis, U. Costabel, D.M. Hansell, and et al. An official american thoracic society/european respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias Am. J. Respir. Crit. Care Med. 188 2013 733 748
23. S. Yoshikawa, K. Tsushima, T. Koizumi, and et al. Hypersensitivity pneumonitis induced by spores of Penicillium citrinum in a worker cultivating Enoki mushroom Intern Med. 45 2006 537 541
24. Y. Hirasawa, N. Kohno, A. Yokoyama, and et al. KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts Am. J. Respir. Cell Mol. Biol. 17 1997 501 507
25. Y. Honda, Y. Kuroki, E. Matsuura, and et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids Am. J. Respir. Crit. Care Med. 152 1995 1860 1866
26. A. Churg, N.L. Muller, J. Flint, and et al. Chronic hypersensitivity pneumonitis Am. J. Surg. Pathol. 30 2006 201 208
27. S. Trahan, V. Hanak, J. Ryu, and et al. Role of surgical lung biopsy in separating chronic hypersensitivity pneumonia from usual interstitial pneumonia/idiopathic pulmonary fibrosis: analysis of 31 biopsies from 15 patients Chest 134 2008 126 132
28. T. Takemura, T. Akashi, H. Kamiya, and et al. Pathological differentiation of chronic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis/usual interstitial pneumonia Histopathology 61 2012 1026 1035
29. D.S. Kim, J.H. Park, B.K. Park, and et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features Eur. Respir. J. 27 2006 143 150
30. J.G. Parambil, J.L. Myers, and J.H. Ryu Histopathologic features and outcome of patients with acute exacerbation of idiopathic pulmonary fibrosis undergoing surgical lung biopsy Chest 128 2005 3310 3315
31. I.N. Park, D.S. Kim, T.S. Shim, and et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis Chest 132 2007 214 220
32. Y. Miyazaki, T. Tateishi, T. Akashi, and et al. Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis Chest 134 2008 1265 1270
33. A. Yokoyama, N. Kohno, H. Hamada, and et al. Circulating KL-6 predicts the outcome of rapidly progressive idiopathic pulmonary fibrosis Am. J. Respir. Crit. Care Med. 158 1998 1680 1684
34. H.R. Collard, C.S. Calfee, P.J. Wolters, and et al. Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis Am. J. Physiol. Lung Cell Mol. Physiol. 299 2010 L3 L7
35. T. Kakugawa, S. Yokota, Y. Ishimatsu, and et al. Serum heat shock protein 47 levels are elevated in acute exacerbation of idiopathic pulmonary fibrosis Cell Stress Chaperones 18 2013 581 590
36. H. Takahashi, T. Fujishima, H. Koba, and et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent Am. J. Respir. Crit. Care Med. 162 2000 1109 1114
37. S.R. Braun, G.A. doPico, A. Tsiatis, and et al. Farmer's lung disease: long-term clinical and physiologic outcome Am. Rev. Respir. Dis. 119 1979 185 191
38. H. Ohnishi, S. Miyamoto, S. Kawase, and et al. Seasonal variation of serum KL-6 concentrations is greater in patients with hypersensitivity pneumonitis BMC Pulm. Med. 14 2014 129
39. T. Okamoto, T. Tsutsui, K. Suhara, and et al. Seasonal variation of serum KL-6 and SP-D levels in bird-related hypersensitivity pneumonitis Sarcoidosis Vasc. Diffuse Lung Dis. 31 2015 364 367